Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Atypical femoral fracture (AFF) often appears with bisphosphonate use. Teriparatide (TPTD) treatment may promote AFF healing, but few controlled or comparative studies have examined the effects of TPTD on healing of bisphosphonate-associated AFF. We retrospectively reviewed the medical records of 45 consecutive AFFs in 34 Japanese patients who had received oral bisphosphonates (alendronate or risedronate) for osteoporosis before AFF and had been followed for ≥12 months (range, 12-90 months). Thirty-seven complete or incomplete AFFs (82 %) were treated surgically and eight incomplete AFFs (18 %) were treated conservatively. Bisphosphonates were stopped at diagnosis. Based on TPTD use after fracture, AFFs were divided into non-TPTD (n = 24) and TPTD (n = 21) groups. Time to fracture-healing and frequency of delayed healing or non-union were compared between groups. Because fracture type (complete or incomplete) differed significantly between groups, only subanalyses for all surgically treated AFFs (complete and incomplete), surgically treated complete AFFs, and conservatively treated incomplete AFFs were performed. In subanalyses for all AFFs treated surgically, mean (± standard deviation) time to fracture healing was significantly better in the TPTD group (5.4 ± 1.5 months) than in the non-TPTD group (8.6 ± 4.7 months; P = 0.012), and the frequency of delayed healing or non-union was significantly lower in the TPTD group than in the non-TPTD group (P = 0.014). Subanalyses for surgically treated complete AFFs yielded similar results, but subanalyses for incomplete AFFs treated conservatively showed no significant differences between groups. TPTD treatment appears to significantly shorten the postoperative time to fracture healing and reduce rates of delayed healing or non-union after bisphosphonate-associated AFF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a retrospective case–control study, Miyakoshi et al. (2015) observed a reduction in healing time and an increased union rate with the use of teriparatide [98].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [98]
Citations
Cites
(2012) · The Scientific World JOURNAL · doi:10.1100/tswj · Cited by 2,595
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147 · cited 8×
“AFF appears to be more common in patients with longterm bisphosphonate use [3, 4].”
BackgroundInfluentialZoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 1×
“Bisphosphonates have been reported to improve quality of life in patients with osteoporosis [1] and to reduce mortality in patients who have sustained hip fractures [2].”
BackgroundAspenberg, P., Genant, H. K., Johansson, T., Nino, A. J., See, K., Krohn, K., García-Hernández, P. A., Recknor, C. P., Einhorn, T. A., Dalsky, G. P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090731 · Cited by 513 · cited 1×
“A randomized clinical trial suggested a role for TPTD in accelerating healing for fractures of the distal radius in postmenopausal women [12].”
BackgroundDiagnostic criteria for primary osteoporosis: year 2000 revision
Orimo, H., Hayashi, Y., Fukunaga, M., Sone, T., Fujiwara, S., Shiraki, M., Kushida, K., Miyamoto, S., Soen, S., Nishimura, J., et al. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170001 · Cited by 465
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
McClung, M., Harris, S. T., Miller, P. D., Bauer, D. C., Davison, K. S., Dian, L., Hanley, D. A., Kendler, D. L., Yuen, C. K., & Lewiecki, E. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.06.023 · Cited by 451 · cited 2×
“However, use of bisphosphonates, particularly for long periods, is associated with an increased risk of atypical femoral fracture (AFF) [3, 4].”
BackgroundRizzoli, R., Åkesson, K., Bouxsein, M., Kanis, J. A., Napoli, N., Papapoulos, S., Reginster, J.-Y., & Cooper, C. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1453-5 · Cited by 249 · cited 1×
“3 years, with an even broader range from 1 to 16 years [21].”
BackgroundThe Outcome of Surgically Treated Femur Fractures Associated With Long-Term Bisphosphonate Use
Weil, Y. A., Rivkin, G., Safran, O., Liebergall, M., & Foldes, A. J. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31821957e3 · Cited by 171 · cited 2×
“Healing of bisphosphonate-associated AFF is usually delayed [5, 6] because of suppressed bone turnover [4], and multiple operations are sometimes required despite careful attention [5, 7, 8].”
BackgroundChiang, C. Y., Zebaze, R., Ghasemzadeh, A., Iuliano-Burns, S., Hardidge, A. J., & Seeman, E. (2012) · Bone · doi:10.1016/j.bone.2012.10.006 · Cited by 153 · cited 4×
“To clarify the healing of AFFs, several case series using bone-forming agents including TPTD have recently been reported [13, 22].”
BackgroundInfluentialSahota, O., Masud, T., San, P., & Hosking, D. J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00764.x · Cited by 140 · cited 4×
“For example, because vitamin D insufficiency is known to negatively impact on BMD [25], vitamin D sufficiency may also be an important factor for healing of bisphosphonate-associated AFF by TPTD.”
BackgroundInfluential
Cited by
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“There is evidence that using anabolic therapy when AFF is diagnosed accelerates fracture healing (325-327).”
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
“(97-99) Based on available reports, a limited course of teriparatide may be considered to accelerate healing of BP-related AFFs or ONJ, consistent with the recommendations of the ASBMR Task Force on Atypical Femoral Fractures and the International Consensus report on ONJ.”
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
“In a retrospective case–control study, Miyakoshi et al. (2015) observed a reduction in healing time and an increased union rate with the use of teriparatide [98].”
Effect of osteoporosis medications on fracture healing
Hegde, V. V., Jo, J. E., Andreopoulou, P., & Lane, J. M. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3331-7 · Cited by 164
“In a retrospective cohort study examining patients surgically treated for both complete and incomplete atypical femoral fractures, time to fracture healing and frequency of delayed healing or nonunion were significantly reduced in the group treated with teriparatide compared to the group that was not [114].”
BackgroundKoh, A., Guerado, E., & Giannoudis, P. V. (2017) · The Bone & Joint Journal · doi:10.1302/0301-620x.99b3.bjj-2016-0276.r2 · Cited by 138
Nonunion of the Femur and Tibia
Bell, A., Templeman, D. C., & Weinlein, J. C. (2016) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.09.010 · Cited by 160
How do bisphosphonates affect fracture healing?
Kates, S. L., & Ackert‐Bicknell, C. L. (2016) · Injury · doi:10.1016/s0020-1383(16)30015-8 · Cited by 129
“[31, 32] One key instance in which many authors report delayed healing to occur is with long-term use of bisphosphonates and development of atypical femoral fractures.[33, 34] Unfortunately, a delay in healing was reported to occur in 26% of cases of these rare fractures.”
Backgroundvan de Laarschot, D. M., McKenna, M. J., Abrahamsen, B., Langdahl, B. L., Cohen-Solal, M. E., Guañabens, N., Eastell, R., Ralston, S. H., & Zillikens, M. C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz295 · Cited by 130
“3), fracture healing could not be assessed with certainty (52, 53), duration of fracture healing or fracture type were not reported (14, 19, 27, 28).”
BackgroundAdler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2918 · Cited by 105
Gorter, E. A., Reinders, C. R., Krijnen, P., Appelman‐Dijkstra, N. M., & Schipper, I. B. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101117 · Cited by 87
Marongiu, G., Dolci, A., Verona, M., & Capone, A. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100249 · Cited by 90
“Both Watts et al. (Watts et al., 2017) and Chiang et al. (Chiang et al., 2013) prospectively evaluated patients with AFFs and a history of previous BPs therapy.”
BackgroundResultInfluentialEffect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review
Im, G., & Lee, S.-H. (2015) · Journal of Bone Metabolism · doi:10.11005/jbm.2015.22.4.183 · Cited by 74
“On the other hand, subanalyses for incomplete AFFs treated conservatively showed no significant differences between the groups.[32] Saleh et al.”
BackgroundInfluentialWatts, N. B., Aggers, D., McCarthy, E. F., Savage, T., Martinez, S., Patterson, R., Carrithers, E., & Miller, P. D. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3081 · Cited by 69
Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia—not atypical at all
Genest, F., & Seefried, L. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4552-3 · Cited by 68
Khow, K. S. F., Shibu, P., Yu, S., Chehade, M. J., & Visvanathan, R. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0652-3 · Cited by 68
“Two studies examined the role of teriparatide postoperatively (29, 31).”
Management of atypical femoral fracture: a scoping review and comprehensive algorithm
Toro, G., Ojeda‐Thies, C., Calabrò, G., Toro, G., Moretti, A., Guerra, G., Caba-Doussoux, P., & Iolascon, G. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1086-8 · Cited by 67
“observed a reduction of healing time and increased union rate [74].”
BackgroundTeriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
Greenspan, S. L., Vujevich, K. T., Britton, C. A., Herradura, A., Gruen, G. S., Tarkin, I. S., Siska, P. A., Hamlin, B., & Perera, S. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4286-7 · Cited by 53
“Miyakoshi and colleagues retrospectively reviewed themedical records of 45 patients with atypical femoral fractures [11].”
Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing
Cheng, C., & Shoback, D. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00501-5 · Cited by 53
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing
Kushchayeva, Y. S., Pestun, I., Kushchayev, S. V., Radzikhovska, N., & Lewiecki, E. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247477 · Cited by 54
Kim, S., Kang, K., Kim, J. W., Lim, S., & Hahn, M. H. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.65 · Cited by 48
“[16-18] In some human study, it seemed to lower the risk of nonunion[19] and reduce healing time of atypical fractures.[20,21] However, small studies to date have directly compared the fracture healing or functional recovery in controlled studies and their answer is still controversial.”
ResultTeriparatide treatment in elderly patients with sacral insufficiency fracture
Yoo, J., Ha, Y., Ryu, H.-J., Chang, G.-W., Lee, Y., Yoo, M. J., & Koo, K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3582 · Cited by 44
Tsuchie, H., Miyakoshi, N., Iba, K., Kasukawa, Y., Nozaka, K., Dohke, T., Kosukegawa, I., Aizawa, T., Maekawa, S., Abé, H., et al. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4658-7 · Cited by 39
Self-citationMembers of IOF Fracture Working Group, Silverman, S. L., Kupperman, E., & Bukata, S. V. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3513-y · Cited by 37
Anabolic agents: what is beyond osteoporosis?
Liu, Y., Levack, A. E., Marty, E., Or, O., Samuels, B., Redko, M., & Lane, J. M. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4507-8 · Cited by 34
Delayed healing of lower limb fractures with bisphosphonate therapy
Yue, B. Y. T., Ng, A., Tang, H. H. F., Joseph, S., & Richardson, M. (2015) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588415x14181254789321 · Cited by 34
“Moreover, recent evidence suggests that teriparatide use accelerates healing in the postoperative setting in BP related atypical femoral fractures.(26) Despite this, there has been no identified benefit of teriparatide use on rates of healing found in papers included in this review.”
BackgroundKim, J. W., Kim, H., Oh, C., Kim, J., Shon, O., Byun, Y.-S., Kim, J. J., Oh, H. K., Minehara, H., Hwang, K. T., et al. (2017) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-017-2764-1 · Cited by 33
Yamashita, J., & McCauley, L. K. (2019) · JBMR Plus · doi:10.1002/jbm4.10250 · Cited by 36
“The medical records of 37 patients who received surgical intervention were reviewed, and healing was compared between patients with and without teriparatide therapy.((75)) Time to healing and the frequency of delayed healing or nonunion were assessed.”
BackgroundMethodResultInfluentialByun, S., Lee, K.-J., Shin, W. C., Moon, N. H., & Kim, C. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06768-w · Cited by 35
“Regarding nonunion, four studies [14, 19, 20, 22] evaluated the incidence of nonunion.”
BackgroundMethodResultInfluentialBilateral atypical femoral fractures: how much symmetry is there on imaging?
Probyn, L. J., Cheung, A. M., Lang, C., Lenchik, L., Adachi, J. D., Khan, A. A., Josse, R. G., TOMLINSON, G. A., & Bleakney, R. R. (2015) · Skeletal Radiology · doi:10.1007/s00256-015-2212-7 · Cited by 32
Osteoporosis: a discussion on the past 5 years
Schweser, K. M., & Crist, B. D. (2017) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-017-9410-y · Cited by 32
Marongiu, G., Contini, A., Lepri, A. C., Donadu, M. G., Verona, M., & Capone, A. (2020) · Bioengineering · doi:10.3390/bioengineering7010022 · Cited by 27
“[98] retrospectively reviewed 45 consecutive AFFs in 34 patients who received long‐term BPs.”
BackgroundAdjuvant Teriparatide Therapy for Surgical Treatment of Femoral Fractures; Does It Work?
Kim, J.-T., Jeong, H. J., Lee, S. J., Kim, H. J., & Yoo, J. J. (2016) · Hip & Pelvis · doi:10.5371/hp.2016.28.3.148 · Cited by 25
Guideline No. 422g: Menopause and Osteoporosis
Khan, A. A., Alrob, H. A., Ali, D. S., Dandurand, K., Wolfman, W., & Fortier, M. P. (2022) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.09.013 · Cited by 28
Atypical femoral fractures and current management
Zheng, N., Tang, N., & Qin, L. (2016) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2016.06.029 · Cited by 26
Bone-seeking agents for the treatment of bone disorders
Cawthray, J. F., Wasan, E. K., & Wasan, K. M. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0394-3 · Cited by 23
Shin, W. C., Moon, N. H., Jang, J. H., Seo, H. U., & Suh, K. T. (2019) · Bone · doi:10.1016/j.bone.2019.08.006 · Cited by 23
Does Teriparatide Improve Fracture Union?: A Systematic Review
Yoon, B., & Kim, K.-C. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.3.167 · Cited by 23
Elbarbary, A. N., Hassen, S., & Badr, I. T. (2020) · Injury · doi:10.1016/j.injury.2020.10.012 · Cited by 20
Short Anabolic Peptides for Bone Growth
Amso, Z., Cornish, J., & Brimble, M. A. (2016) · Medicinal Research Reviews · doi:10.1002/med.21388 · Cited by 21
Snyder-Robinson syndrome: differential diagnosis of osteogenesis imperfecta
Valera-Ribera, C., Martinez-Ferrer, A., Fernández, E., Gómez, I. V., Vera, A. O., Pascual, E. V., García, D. Y., & Sancho, J. J. A. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06228-3 · Cited by 19
“1 3 similar cases, changing the treatment from bisphosphonates to a teriparatide regime has shown positive outcomes [6].”
BackgroundManagement of Osteoporosis Medication after Osteoporotic Fracture
Oh, Y. K., Moon, N. H., & Shin, W. C. (2022) · Hip & Pelvis · doi:10.5371/hp.2022.34.4.191 · Cited by 20
Kulachote, N., Sa-ngasoongsong, P., Sirisreetreerux, N., Chanplakorn, P., Fuangfa, P., Suphachatwong, C., & Wajanavisit, W. (2016) · BioMed Research International · doi:10.1155/2016/4061539 · Cited by 19
“Fracture healing after 6months was defined as delayed union [15], while fractures without increased callus formation after 6 months on follow-up radiographs or those who had hardware failure were defined as nonunion [14].”
BackgroundResultInfluentialManagement of difficult osteoporosis
Russell, L. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.04.002 · Cited by 20
Fracture Risk Following an Atypical Femoral Fracture
Bégin, M., Audet, M.-C., Chevalley, T., Portela, M., Padlina, I., Hannouche, D., Lorenzini, K. I., Meier, R. P. H., Peter, R. E., Uebelhart, B., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4461 · Cited by 18
“Whether these drugs might also improve AFF healing in this context is less established in observational studies.((40-43)) The results of the first randomized placebo-controlled trial testing teriparatide for the healing of incomplete AFF (TAFF trial), were recently reported.”
BackgroundTakakubo, Y., Ohta, D., Ishi, M., Ito, J., Oki, H., Naganuma, Y., Uno, T., Sasaki, A., Akabane, T., Dairaku, K., et al. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.327 · Cited by 18
“Teriparatide has been shown to possibly accelerate the healing of AFFs (Shane et al. 2014; Schilcher 2015; Miyakoshi et al. 2015); however, Watts et al. (2017) did not find a consistent effect of teriparatide on healing of AFFs.”
BackgroundMiura, T., Kijima, H., Tani, T., Ebina, T., Miyakoshi, N., & Shimada, Y. (2019) · Case Reports in Surgery · doi:10.1155/2019/9845320 · Cited by 16
“Teriparatide is reported to signi fi cantly shorten post-operative recovery and reduce rates of delayed healing or nonunion in patients with AFFs, and AFFs and PAFFs are thought to have a similar pathogenic mechanism [21].”
Self-citationCompliance with established guidelines for the radiological reporting of atypical femoral fractures
Harborne, K., Hazlehurst, J., Shanmugaratnam, H., Pearson, S. M., Doyle, A., Gittoes, N. J. L., Choudhary, S., & Crowley, R. K. (2015) · British Journal of Radiology · doi:10.1259/bjr.20150443 · Cited by 16
Tan, J., Sano, H., & Poole, K. E. S. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-229366 · Cited by 17
Nguyen, H. H., Milat, F., & Ebeling, P. R. (2017) · Bone Reports · doi:10.1016/j.bonr.2017.01.002 · Cited by 16
“…studies investigating TPTD therapy in the management of AFF, have shown that it may aid fracture healing of incomplete AFFwithout radiological cortical lucency (Saleh et al., 2012), and can reduce fracture healing time and rates of non-union in the post-operative setting (Miyakoshi et al., 2015).”
BackgroundKasukawa, Y., Miyakoshi, N., Ebina, T., Hongo, M., Ishikawa, Y., Kudo, D., Nozaka, K., & Shimada, Y. (2017) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2017.14.1.140 · Cited by 16
Self-citationHenssler, L., Kerschbaum, M., Mukashevich, M. Z., Rupp, M., & Alt, V. (2021) · Injury · doi:10.1016/j.injury.2021.04.068 · Cited by 14
Ferreira, P., Bates, P., Daoub, A., & Dass, D. (2022) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2022.103475 · Cited by 14
Evaluation and management of atypical femoral fractures: an update of current knowledge
Pearce, O., Edwards, T., Al-Hourani, K., Kelly, M., & Riddick, A. (2021) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-021-02896-3 · Cited by 15
Salamah, H. M., Abualkhair, K. A., Kamal, S. K., Mohamed, H. A., Alkheder, A., Farho, M. A., Mistry, D., & Elbardesy, H. (2023) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-023-05171-8 · Cited by 14
Shon, O., Yoon, J. Y., & Kim, J. W. (2020) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-020-03524-1 · Cited by 12
Makino, A., Hasegawa, T., Yamamoto, T., Takagi, H., Takahashi, Y., Miyakoshi, N., & Amizuka, N. (2024) · Bone · doi:10.1016/j.bone.2024.117056 · Cited by 11
Self-citationJeong, S.-Y., Hwang, K. T., Oh, C., Kim, J., Sohn, O. J., Kim, J. W., Cho, Y.-H., & Park, K. C. (2021) · The Bone & Joint Journal · doi:10.1302/0301-620x.103b11.bjj-2021-0416.r1 · Cited by 10
Long-term consequences of osteoporosis therapy with denosumab
Bandeira, F. A. F., de Oliveira, L. B., & Bilezikian, J. P. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000560 · Cited by 10
“There is no significant evidence that indicates a specific treatment for patients who had AFF; however, there are data that suggest that anabolic drugs, such as teriparatide, can accelerate healing (5,31,32).”
BackgroundBisphosphonates in the treatment of osteoporosis: a review of skeletal safety concerns
Habib, Z. A. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1256199 · Cited by 9
Effects of teriparatide on fusion rates in patients undergoing complex foot and ankle arthrodesis
Lee, H. S., Park, J. H., Suh, D. H., Kim, H. J., Koo, B. M., Kim, H. K., Yang, S. H., & Choi, G. W. (2019) · Foot and Ankle Surgery · doi:10.1016/j.fas.2019.10.002 · Cited by 9
Alnajmi, R. A. Y., Ali, D. S., & Khan, A. A. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.08.007 · Cited by 9
The Effect of Teriparatide on the Hip: A Literature Review
Kim, K., Won, Y., Lee, S.-W., & Seo, K.-D. (2021) · Hip & Pelvis · doi:10.5371/hp.2021.33.2.45 · Cited by 8
LEIGHTON, R. K., Robinson, J. D. D., & Giannoudis, P. V. (2019) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001642 · Cited by 8
The Effects of Long-term Use of Nitrogen-containing Bisphosphonates on Fracture Healing
Begkas, D., Pastroudis, A., Touzopoulos, P., Markeas, N. G., & Chatzopoulos, S.-T. (2019) · Cureus · doi:10.7759/cureus.4307 · Cited by 7
“Key cases where many authors report a delay in endochondral fracture healing are in previous long-term use of N-BPs, as well as in the treatment of atypical femoral fractures associated with N-BPs [41-42].”
BackgroundGao, J., Liu, X., Wu, X., Li, X., Liu, J., & Li, M. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1063170 · Cited by 7
Fang, C. X., Shen, W. Y., Wong, J. S. H., Yee, D. K. H., Yung, C. S.-Y., Fang, E., Lai, Y. S., Woo, S.-B., Cheung, J., Chau, J. Y. M., et al. (2023) · Injury · doi:10.1016/j.injury.2023.110909 · Cited by 7
Comparison of Atypical and Osteoporotic Femoral Shaft Fractures in the Elderly: A Multicenter Study
Miura, T., Kijima, H., Ishikawa, N., Ebina, T., Tani, T., Chida, S., Suzuki, T., Yumto, S., Tazawa, H., Miyakoshi, N., et al. (2018) · Advances in Orthopedics · doi:10.1155/2018/1068053 · Cited by 7
Self-citationTakakubo, Y., Miyaji, T., Ohta, D., Ito, J., Oki, H., Momma, R., Naganuma, Y., Honma, R., Akabane, T., Uno, T., et al. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-021-01215-4 · Cited by 7
Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
Miyakoshi, N., Horikawa, A., & Shimada, Y. (2015) · Case Reports in Orthopedics · doi:10.1155/2015/784360 · Cited by 7
“In our recent study, teriparatide treatment significantly shortened the time to fracture healing and reduced rates of delayed healing or nonunion after bisphosphonate-associated atypical femoral fractures [14].”
BackgroundSelf-citationLong-term radiographic follow-up of bisphosphonate-associated atypical femur fractures
Favinger, J. L., Hippe, D. S., & Ha, A. S. (2016) · Skeletal Radiology · doi:10.1007/s00256-016-2346-2 · Cited by 7
Yoon, B., Kim, M., & Roh, Y. H. (2024) · Clinics in Orthopedic Surgery · doi:10.4055/cios23386 · Cited by 6
Aki, T., Hashimoto, K., Uozumi, H., Saito, M., Sugawara, K., Suzuki, M., Hamada, S., Ito, A., & Itoi, E. (2021) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.253.261 · Cited by 6
“However, several reports indicate that long-term bisphosphonate administration negatively influences the bone healing process of a human atypical fracture (Edwards et al. 2013, Egol et al. 2014, Miyakoshi et al. 2015, Kates and Ackert-Bicknell 2016).”
BackgroundOptimum duration and safety of long-term use of potent anti-resorptive medications in osteoporosis
Wimalawansa, S. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1202111 · Cited by 6
Meccariello, L., Cusano, G., Meluccio, A., Gigante, A. P., & Matera, L. (2025) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2025.11.011 · Cited by 5
Therapeutic strategy for atypical ulnar fracture in long use of bisphosphonate: A systematic review
Hirokawa, T., Zukawa, M., Makino, H., Osada, R., & Kawaguchi, Y. (2023) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2023.03.009 · Cited by 5
Bilateral atypical fractures of the femur: Ten years AFTER ten years of bisphosphonate therapy
Smith, M. D., Haseman, O. J., Garza, J. A. V., & Bruder, J. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101112 · Cited by 5
Uehara, M., Nakamura, Y., Takahashi, J. A., Isobe, F., Ikegami, S., Suzuki, T., Uchiyama, S., Kamimura, M., & Kato, H. (2017) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2017.1361373 · Cited by 4
Kawaguchi, H. (2025) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-025-01589-9 · Cited by 4
“For atypical femoral fractures (AFF), which are a recognized adverse event of antiresorptive drugs, some observational studies have suggested that sequential therapy with teriparatide may accelerate post-surgical fracture healing [10–13].”
Outside the Bone: What Is Happening Systemically to Influence Fracture Healing?
Kates, S. L., Satpathy, J., Petrisor, B. A., Konda, S. R., McKee, M. D., & Schemitsch, E. H. (2018) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001116 · Cited by 4
Png, M. A., Koh, J. S. B., Mohan, P. C., Howe, C. Y., & Howe, T. S. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01378-8 · Cited by 4
“[19] which showed a better healing rate and faster healing in iAFF treated medically with teriparatide but which was also not statistically significant.”
BackgroundKondo, N., Miyasaka, D., Watanabe, Y., Sato, H., Kanda, T., & Endo, N. (2019) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2019.1650992 · Cited by 4
“Teriparatide was reported to be effective for promoting fracture healing in patients with AFFs who underwent open reduction and internal fixation surgery compared to those who received non-teriparatide treatment [7,8].”
ResultTeriparatide in the Prevention and Treatment of Osteoporosis: an Update
Adami, G., Rossini, M., & Viapiana, O. (2025) · Clinical & Translational Metabolism · doi:10.1007/s12018-025-09320-y · Cited by 3
“…teriparatide therapy acceler - ated the healing of complete or incomplete AFFs after 18 weeks (vs. 23 weeks in those who did not receive teripa - ratide; P = 0.01) [73 ] and after 5.4 months (vs. 8.6 months without teriparatide; P = 0.012) in a subgroup of surgically treated patients [74 ].”
InfluentialTsuchie, H., Miyakoshi, N., Kasukawa, Y., Nozaka, K., Saito, K., Kinoshita, H., Kobatyashi, M., Suzuki, N., Aizawa, T., Abe, H., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115671 · Cited by 3
Self-citationRoy, A. N., & Mazumdar, I. (2023) · Cureus · doi:10.7759/cureus.45662 · Cited by 3
“Additionally, the TPTD group had a significantly lower frequency of delayed healing or non-union compared to the non-TPTD group (p = 0.014) [27].”
InfluentialTeriparatide Does not Have Beneficial Effects on Bone Healing in Complete Atypical Femur Fractures
Song, G., Jeong, Y., Nam, W. D., & Kim, K.-H. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01244-x · Cited by 3
“Miyakoshi et al. conducted a comparative study of 45 cases and revealed that the period of bone healing was significantly shorter in the teriparatide group in AFF, and that the occurrence of delayed union or nonunion was significantly less [20].”
Atypical Femoral Fracture in a Patient with Metastatic Breast Cancer During Denosumab Therapy
Ohnaru, K. (2016) · Journal of Clinical Case Reports · doi:10.4172/2165-7920.1000737 · Cited by 2
“Moreover, recent reports suggest that teriparatide may assist in AFF healing [15,16].”
BackgroundKim, Y. S., Lee, H. M., Kim, J. P., Bae, E. W., Oh, C., & Kim, J. W. (2020) · Minerva Ortopedica e Traumatologica · doi:10.23736/s0394-3410.20.03965-x · Cited by 2
Atypical Femoral Fracture Despite Prophylactic Intramedullary Nailing: A Case Report
Schemitsch, C. E., Kuzyk, P. R. T., & McKee, M. D. (2015) · JBJS Case Connector · doi:10.2106/jbjs.cc.n.00066 · Cited by 2
Sacral Insufficiency Fractures
Shepard, N. A., & Tejwani, N. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-33861-9_19 · Cited by 1
Choi, S. H., Lee, M. G., Cho, Y. J., Chun, Y. S., & Rhyu, K. H. (2025) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/21514593251403400 · Cited by 1
Osteoporosis, Fracture Healing and Teriparatide
Borges, J. L. C., & Santiago, I. I. (2016) · Spine Research · doi:10.21767/2471-8173.100020 · Cited by 1
Oh, H. C., Yoo, J.-H., Ha, J. W., Park, Y., Park, S. H., & Yoon, H. K. (2020) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2020.55.3.237 · Cited by 1
Bone Health and Orthopedic Surgery
Russell, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35570-8_30 · Cited by 1
Yasukawa, T., Lee, S. Y., Hasegawa, H., Tsuchiya, K., Shirahata, T., Yoshimura, M., & Kudo, Y. (2024) · Trauma Case Reports · doi:10.1016/j.tcr.2024.101005 · Cited by 1
“The administration of teriparatide, an anabolic agent used for osteoporosis treatment, has been found to improve bone healing and reduce time to union in AFFs [7].”
BackgroundInfluentialApplications of Teriparatide for Fracture Repair and Osteosynthetic Surgery in Osteoporosis
Nozaka, K., Miyakoshi, N., & Shimada, Y. (2015) · Springer eBooks · doi:10.1007/978-4-431-55778-4_10
Self-citationTeriparatide Treatment for An Atypical Fracture of the Femoral Shaft: A Case Report
Oshita, Y., Kuroda, T., Ishikawa, K., Nagai, T., Kawasaki, K., Kanzaki, K., & Inagaki, K. (2019) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.31.73
Makunts, T., Anwar, L. S., & Abagyan, R. A. (2020) · medRxiv · doi:10.1101/2020.06.15.20132290
“However, many case reports and small-scale studies have shown the association of bisphosphonate use with AFF for alendronate, ibandronate, risedronate, zoledronic acid, and denosumab[19-27].”
Atypical Femoral Fracture Occurring Within 2 Years of Denosumab Use
Suenaga, E., Sumiyoshi, Y., & Takata, M. (2021) · Orthopedics & Traumatology · doi:10.5035/nishiseisai.70.209
Metadata
- Authors
- Miyakoshi, N., Aizawa, T., Sasaki, S., Ando, S., Maekawa, S., Aonuma, H., Tsuchie, H., Sasaki, H., Kasukawa, Y., & Shimada, Y.
- Affiliations
- Akita University (JP)
- Ogachi Central Hospital (JP)
- Nakadōri General Hospital (JP)
- Akita Rosai Hospital (JP)
- Corresponding author
- Miyakoshi, Naohisa
- ORCID
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2014-09-17
- Volume
- 33
- Issue
- 5
- Pages
- 553-559
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W1996444160
- Cited by
- 114
- References
- 27
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 13 · 2019: 12 · 2018: 6 · 2017: 13 · 2016: 15 · 2015: 10 · 2014: 1
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- atypical femoral fractures, teriparatide, fracture healing, osteoporosis, alendronate, risedronate, nonunion, delayed healing, bisphosphonate discontinuation, fracture surgery
- MeSH terms
- Aged, Aged, 80 and over, Diphosphonates, Female, Femoral Fractures, Humans, Osteoporosis, Retrospective Studies, Fracture Healing, Teriparatide, Alendronate, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.